Book contents
- 50 Big Debates in Gynecologic Oncology
- 50 Big Debates in Gynecologic Oncology
- Copyright page
- Contents
- Contributors
- Section I Perioperative Management
- Section II Screening, Prevention, and Early Diagnosis
- Debate 3A Should Women with BRCA Mutations be Offered Bilateral Salpingectomy with Delayed Oophorectomy for Ovarian Cancer Risk Reduction?
- Chapter 3B Should Women with BRCA Mutations be Offered Bilateral Salpingectomy with Delayed Oophorectomy for Ovarian Cancer Risk Reduction?
- Debate 4A Can High-risk HPV Testing be Used Alone as the Primary Screening Modality for Cervical Cancer?
- Debate 4B Can High-risk HPV Testing be Used Alone as the Primary Screening Modality for Cervical Cancer?
- Section III Ovarian Cancer
- Section IV Endometrial Cancer
- Section V Cervical Cancer
- Section VI Vaginal and Vulvar Cancer
- Index
- References
Debate 3A - Should Women with BRCA Mutations be Offered Bilateral Salpingectomy with Delayed Oophorectomy for Ovarian Cancer Risk Reduction?
Yes
from Section II - Screening, Prevention, and Early Diagnosis
Published online by Cambridge University Press: 20 July 2023
- 50 Big Debates in Gynecologic Oncology
- 50 Big Debates in Gynecologic Oncology
- Copyright page
- Contents
- Contributors
- Section I Perioperative Management
- Section II Screening, Prevention, and Early Diagnosis
- Debate 3A Should Women with BRCA Mutations be Offered Bilateral Salpingectomy with Delayed Oophorectomy for Ovarian Cancer Risk Reduction?
- Chapter 3B Should Women with BRCA Mutations be Offered Bilateral Salpingectomy with Delayed Oophorectomy for Ovarian Cancer Risk Reduction?
- Debate 4A Can High-risk HPV Testing be Used Alone as the Primary Screening Modality for Cervical Cancer?
- Debate 4B Can High-risk HPV Testing be Used Alone as the Primary Screening Modality for Cervical Cancer?
- Section III Ovarian Cancer
- Section IV Endometrial Cancer
- Section V Cervical Cancer
- Section VI Vaginal and Vulvar Cancer
- Index
- References
Summary
The fimbriated end of the fallopian tube plays a pivotal role in the pathogenesis of pelvic high-grade serous carcinomas (HGSC). While risk-reducing salpingo-oohprectomy (RRSO) is the standard of care for patients with genetic risk for developing HGSC, the detrimental effects of premature menopause on both health and quality of life are unacceptable to many patients. Risk-reducing early salpingectomy with delayed oophorectomy (RRESDO) has the potential to offer risk-reduction, without the toxicity of premature menopause and infertility. An individualized “previvorship” plan incorporating this option allows for patient-centered planning, with the potential for enhanced quality of life, earlier detection of precursor lesions, and possibly a greater impact in risk-reduction.
- Type
- Chapter
- Information
- 50 Big Debates in Gynecologic Oncology , pp. 11 - 12Publisher: Cambridge University PressPrint publication year: 2023